Webinar Replay: GLP-1 Drugs to Reduce Symptoms in People with ME/CFS and Identify Disease Subgroups
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the natural GLP-1 hormone, which helps regulate insulin levels. Thus, these medicines help control blood sugar […]
GLP-1 Drugs to Reduce Symptoms in People with ME/CFS and Identify Disease Subgroups
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the natural GLP-1 hormone, which helps regulate insulin levels. Thus, these medicines help control blood sugar […]
New Catalyst Awards to Accelerate ME/CFS and Long Covid Breakthroughs
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS Catalyst Awards, a focused initiative to support promising research projects that have already made significant […]
2025 Advocacy in Review: What You Helped Push Forward
This year, you made the difference. In a year filled with gridlock for biomedical research and public health, your voice kept ME/CFS on the agenda. You showed up, spoke out, […]